Global Ketoconazole API Market Research Report 2023

Publication ID:

PB504244376

Publication Date:

May 4, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Ketoconazole is an antifungal medication used to treat a number of fungal infections. Applied to the skin it is used for fungal skin infections such as tinea, cutaneous candidiasis, pityriasis versicolor, dandruff, and seborrheic dermatitis. Taken by mouth it is a less preferred option and only recommended for severe infections when other agents cannot be used. Other uses include in the treatment of excessive hair growth and Cushing's syndrome.
The global Ketoconazole API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Ketoconazole API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Ketoconazole API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Ketoconazole API include UQUIFA, Olon, Piramal Enterprises Limited, SALVAVIDAS PHARMACEUTICAL, FENGCHEN GROUP CO., LTD, INDIES GLOBAL LIMITED, Triveni Interchem Private Limited, Jiangsu Nhwa Pharmaceutical Co., Ltd. and Baijingyu Pharmaceutical, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ketoconazole API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketoconazole API.
The Ketoconazole API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Ketoconazole API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ketoconazole API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
UQUIFA
Olon
Piramal Enterprises Limited
SALVAVIDAS PHARMACEUTICAL
FENGCHEN GROUP CO., LTD
INDIES GLOBAL LIMITED
Triveni Interchem Private Limited
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Baijingyu Pharmaceutical
Zhejiang East Asia Pharmaceutical Co., Ltd.
Segment by Type
笔耻谤颈迟测鈮�99%
Purity<99%
Segment by Application
Ketoconazole Tablet
Ketoconazole Ointment
Ketoconazole Lotion
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ketoconazole API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Ketoconazole API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Ketoconazole API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Ketoconazole API Market Overview
1.1 Product Definition
1.2 Ketoconazole API Segment by Type
1.2.1 Global Ketoconazole API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 笔耻谤颈迟测鈮�99%
1.2.3 Purity<99%
1.3 Ketoconazole API Segment by Application
1.3.1 Global Ketoconazole API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Ketoconazole Tablet
1.3.3 Ketoconazole Ointment
1.3.4 Ketoconazole Lotion
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Ketoconazole API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Ketoconazole API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Ketoconazole API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Ketoconazole API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Ketoconazole API Production Market Share by Manufacturers (2018-2023)
2.2 Global Ketoconazole API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Ketoconazole API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Ketoconazole API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Ketoconazole API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Ketoconazole API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ketoconazole API, Product Offered and Application
2.8 Global Key Manufacturers of Ketoconazole API, Date of Enter into This Industry
2.9 Ketoconazole API Market Competitive Situation and Trends
2.9.1 Ketoconazole API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Ketoconazole API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Ketoconazole API Production by Region
3.1 Global Ketoconazole API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Ketoconazole API Production Value by Region (2018-2029)
3.2.1 Global Ketoconazole API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Ketoconazole API by Region (2024-2029)
3.3 Global Ketoconazole API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Ketoconazole API Production by Region (2018-2029)
3.4.1 Global Ketoconazole API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Ketoconazole API by Region (2024-2029)
3.5 Global Ketoconazole API Market Price Analysis by Region (2018-2023)
3.6 Global Ketoconazole API Production and Value, Year-over-Year Growth
3.6.1 North America Ketoconazole API Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Ketoconazole API Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Ketoconazole API Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Ketoconazole API Production Value Estimates and Forecasts (2018-2029)
4 Ketoconazole API Consumption by Region
4.1 Global Ketoconazole API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Ketoconazole API Consumption by Region (2018-2029)
4.2.1 Global Ketoconazole API Consumption by Region (2018-2023)
4.2.2 Global Ketoconazole API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Ketoconazole API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Ketoconazole API Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ketoconazole API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Ketoconazole API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ketoconazole API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Ketoconazole API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ketoconazole API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Ketoconazole API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Ketoconazole API Production by Type (2018-2029)
5.1.1 Global Ketoconazole API Production by Type (2018-2023)
5.1.2 Global Ketoconazole API Production by Type (2024-2029)
5.1.3 Global Ketoconazole API Production Market Share by Type (2018-2029)
5.2 Global Ketoconazole API Production Value by Type (2018-2029)
5.2.1 Global Ketoconazole API Production Value by Type (2018-2023)
5.2.2 Global Ketoconazole API Production Value by Type (2024-2029)
5.2.3 Global Ketoconazole API Production Value Market Share by Type (2018-2029)
5.3 Global Ketoconazole API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Ketoconazole API Production by Application (2018-2029)
6.1.1 Global Ketoconazole API Production by Application (2018-2023)
6.1.2 Global Ketoconazole API Production by Application (2024-2029)
6.1.3 Global Ketoconazole API Production Market Share by Application (2018-2029)
6.2 Global Ketoconazole API Production Value by Application (2018-2029)
6.2.1 Global Ketoconazole API Production Value by Application (2018-2023)
6.2.2 Global Ketoconazole API Production Value by Application (2024-2029)
6.2.3 Global Ketoconazole API Production Value Market Share by Application (2018-2029)
6.3 Global Ketoconazole API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 UQUIFA
7.1.1 UQUIFA Ketoconazole API Corporation Information
7.1.2 UQUIFA Ketoconazole API Product Portfolio
7.1.3 UQUIFA Ketoconazole API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 UQUIFA Main Business and Markets Served
7.1.5 UQUIFA Recent Developments/Updates
7.2 Olon
7.2.1 Olon Ketoconazole API Corporation Information
7.2.2 Olon Ketoconazole API Product Portfolio
7.2.3 Olon Ketoconazole API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Olon Main Business and Markets Served
7.2.5 Olon Recent Developments/Updates
7.3 Piramal Enterprises Limited
7.3.1 Piramal Enterprises Limited Ketoconazole API Corporation Information
7.3.2 Piramal Enterprises Limited Ketoconazole API Product Portfolio
7.3.3 Piramal Enterprises Limited Ketoconazole API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Piramal Enterprises Limited Main Business and Markets Served
7.3.5 Piramal Enterprises Limited Recent Developments/Updates
7.4 SALVAVIDAS PHARMACEUTICAL
7.4.1 SALVAVIDAS PHARMACEUTICAL Ketoconazole API Corporation Information
7.4.2 SALVAVIDAS PHARMACEUTICAL Ketoconazole API Product Portfolio
7.4.3 SALVAVIDAS PHARMACEUTICAL Ketoconazole API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 SALVAVIDAS PHARMACEUTICAL Main Business and Markets Served
7.4.5 SALVAVIDAS PHARMACEUTICAL Recent Developments/Updates
7.5 FENGCHEN GROUP CO., LTD
7.5.1 FENGCHEN GROUP CO., LTD Ketoconazole API Corporation Information
7.5.2 FENGCHEN GROUP CO., LTD Ketoconazole API Product Portfolio
7.5.3 FENGCHEN GROUP CO., LTD Ketoconazole API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 FENGCHEN GROUP CO., LTD Main Business and Markets Served
7.5.5 FENGCHEN GROUP CO., LTD Recent Developments/Updates
7.6 INDIES GLOBAL LIMITED
7.6.1 INDIES GLOBAL LIMITED Ketoconazole API Corporation Information
7.6.2 INDIES GLOBAL LIMITED Ketoconazole API Product Portfolio
7.6.3 INDIES GLOBAL LIMITED Ketoconazole API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 INDIES GLOBAL LIMITED Main Business and Markets Served
7.6.5 INDIES GLOBAL LIMITED Recent Developments/Updates
7.7 Triveni Interchem Private Limited
7.7.1 Triveni Interchem Private Limited Ketoconazole API Corporation Information
7.7.2 Triveni Interchem Private Limited Ketoconazole API Product Portfolio
7.7.3 Triveni Interchem Private Limited Ketoconazole API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Triveni Interchem Private Limited Main Business and Markets Served
7.7.5 Triveni Interchem Private Limited Recent Developments/Updates
7.8 Jiangsu Nhwa Pharmaceutical Co., Ltd.
7.8.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Ketoconazole API Corporation Information
7.8.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Ketoconazole API Product Portfolio
7.8.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Ketoconazole API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Main Business and Markets Served
7.7.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Developments/Updates
7.9 Baijingyu Pharmaceutical
7.9.1 Baijingyu Pharmaceutical Ketoconazole API Corporation Information
7.9.2 Baijingyu Pharmaceutical Ketoconazole API Product Portfolio
7.9.3 Baijingyu Pharmaceutical Ketoconazole API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Baijingyu Pharmaceutical Main Business and Markets Served
7.9.5 Baijingyu Pharmaceutical Recent Developments/Updates
7.10 Zhejiang East Asia Pharmaceutical Co., Ltd.
7.10.1 Zhejiang East Asia Pharmaceutical Co., Ltd. Ketoconazole API Corporation Information
7.10.2 Zhejiang East Asia Pharmaceutical Co., Ltd. Ketoconazole API Product Portfolio
7.10.3 Zhejiang East Asia Pharmaceutical Co., Ltd. Ketoconazole API Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Zhejiang East Asia Pharmaceutical Co., Ltd. Main Business and Markets Served
7.10.5 Zhejiang East Asia Pharmaceutical Co., Ltd. Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ketoconazole API Industry Chain Analysis
8.2 Ketoconazole API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ketoconazole API Production Mode & Process
8.4 Ketoconazole API Sales and Marketing
8.4.1 Ketoconazole API Sales Channels
8.4.2 Ketoconazole API Distributors
8.5 Ketoconazole API Customers
9 Ketoconazole API Market Dynamics
9.1 Ketoconazole API Industry Trends
9.2 Ketoconazole API Market Drivers
9.3 Ketoconazole API Market Challenges
9.4 Ketoconazole API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

UQUIFA
Olon
Piramal Enterprises Limited
SALVAVIDAS PHARMACEUTICAL
FENGCHEN GROUP CO., LTD
INDIES GLOBAL LIMITED
Triveni Interchem Private Limited
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Baijingyu Pharmaceutical
Zhejiang East Asia Pharmaceutical Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂